Quality of life in schizophrenia and bipolar disorder

The impact of symptomatic remission and resilience

A. Hofer, Y. Mizuno, F. Wartelsteiner, W. Wolfgang Fleischhacker, B. Frajo-Apor, G. Kemmler, Masaru Mimura, S. Pardeller, C. Sondermann, T. Suzuki, A. Welte, Hiroyuki Uchida

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background Health-related quality of life (HRQOL) is significantly affected in individuals with schizophrenia or bipolar I disorder (BD-I). The current study investigated whether symptomatic remission and resilience might differently impact HRQOL in these patients. Methods Fifty-two patients with schizophrenia and 60 patients suffering from BD-I from outpatient mental health services as well as 77 healthy control subjects from the general community were included into a cross-sectional study. HRQOL and resilience were assessed using the WHOQOL-BREF and the Resilience Scale. In patients, psychopathology was quantified by the Positive and Negative Syndrome Scale or the Montgomery Asberg Depression Rating Scale and the Young Mania Rating Scale, respectively. Results Notably, both patient groups showed lower HRQOL and resilience compared to control subjects, non-remitted patients indicated lower HRQOL than remitted ones. The effect of remission on HRQOL was significantly larger in patients with BD-I than in those with schizophrenia but did not explain the difference in HRQOL between groups. Resilience predicted HRQOL in all three groups. When accounting for the effect of resilience among remitted patients, only the difference in HRQOL between schizophrenia patients and control subjects was significant. Conclusion These findings demonstrate the impact of symptomatic remission and resilience on HRQOL of both patients suffering from schizophrenia and BD-I and indicate that these factors are especially relevant for HRQOL of patients with BD-I.

Original languageEnglish
Pages (from-to)42-47
Number of pages6
JournalEuropean Psychiatry
Volume46
DOIs
Publication statusPublished - 2017 Oct 1

Fingerprint

Bipolar Disorder
Schizophrenia
Quality of Life
Mental Health Services
Ambulatory Care
Psychopathology
Healthy Volunteers
Cross-Sectional Studies
Depression

Keywords

  • Bipolar disorder
  • Quality of life
  • Remission
  • Resilience
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Quality of life in schizophrenia and bipolar disorder : The impact of symptomatic remission and resilience. / Hofer, A.; Mizuno, Y.; Wartelsteiner, F.; Wolfgang Fleischhacker, W.; Frajo-Apor, B.; Kemmler, G.; Mimura, Masaru; Pardeller, S.; Sondermann, C.; Suzuki, T.; Welte, A.; Uchida, Hiroyuki.

In: European Psychiatry, Vol. 46, 01.10.2017, p. 42-47.

Research output: Contribution to journalArticle

Hofer, A, Mizuno, Y, Wartelsteiner, F, Wolfgang Fleischhacker, W, Frajo-Apor, B, Kemmler, G, Mimura, M, Pardeller, S, Sondermann, C, Suzuki, T, Welte, A & Uchida, H 2017, 'Quality of life in schizophrenia and bipolar disorder: The impact of symptomatic remission and resilience', European Psychiatry, vol. 46, pp. 42-47. https://doi.org/10.1016/j.eurpsy.2017.08.005
Hofer A, Mizuno Y, Wartelsteiner F, Wolfgang Fleischhacker W, Frajo-Apor B, Kemmler G et al. Quality of life in schizophrenia and bipolar disorder: The impact of symptomatic remission and resilience. European Psychiatry. 2017 Oct 1;46:42-47. https://doi.org/10.1016/j.eurpsy.2017.08.005
Hofer, A. ; Mizuno, Y. ; Wartelsteiner, F. ; Wolfgang Fleischhacker, W. ; Frajo-Apor, B. ; Kemmler, G. ; Mimura, Masaru ; Pardeller, S. ; Sondermann, C. ; Suzuki, T. ; Welte, A. ; Uchida, Hiroyuki. / Quality of life in schizophrenia and bipolar disorder : The impact of symptomatic remission and resilience. In: European Psychiatry. 2017 ; Vol. 46. pp. 42-47.
@article{e5c89fdfd2ee40808dcd82cc738bb20c,
title = "Quality of life in schizophrenia and bipolar disorder: The impact of symptomatic remission and resilience",
abstract = "Background Health-related quality of life (HRQOL) is significantly affected in individuals with schizophrenia or bipolar I disorder (BD-I). The current study investigated whether symptomatic remission and resilience might differently impact HRQOL in these patients. Methods Fifty-two patients with schizophrenia and 60 patients suffering from BD-I from outpatient mental health services as well as 77 healthy control subjects from the general community were included into a cross-sectional study. HRQOL and resilience were assessed using the WHOQOL-BREF and the Resilience Scale. In patients, psychopathology was quantified by the Positive and Negative Syndrome Scale or the Montgomery Asberg Depression Rating Scale and the Young Mania Rating Scale, respectively. Results Notably, both patient groups showed lower HRQOL and resilience compared to control subjects, non-remitted patients indicated lower HRQOL than remitted ones. The effect of remission on HRQOL was significantly larger in patients with BD-I than in those with schizophrenia but did not explain the difference in HRQOL between groups. Resilience predicted HRQOL in all three groups. When accounting for the effect of resilience among remitted patients, only the difference in HRQOL between schizophrenia patients and control subjects was significant. Conclusion These findings demonstrate the impact of symptomatic remission and resilience on HRQOL of both patients suffering from schizophrenia and BD-I and indicate that these factors are especially relevant for HRQOL of patients with BD-I.",
keywords = "Bipolar disorder, Quality of life, Remission, Resilience, Schizophrenia",
author = "A. Hofer and Y. Mizuno and F. Wartelsteiner and {Wolfgang Fleischhacker}, W. and B. Frajo-Apor and G. Kemmler and Masaru Mimura and S. Pardeller and C. Sondermann and T. Suzuki and A. Welte and Hiroyuki Uchida",
year = "2017",
month = "10",
day = "1",
doi = "10.1016/j.eurpsy.2017.08.005",
language = "English",
volume = "46",
pages = "42--47",
journal = "European Psychiatry",
issn = "0924-9338",
publisher = "Elsevier Masson",

}

TY - JOUR

T1 - Quality of life in schizophrenia and bipolar disorder

T2 - The impact of symptomatic remission and resilience

AU - Hofer, A.

AU - Mizuno, Y.

AU - Wartelsteiner, F.

AU - Wolfgang Fleischhacker, W.

AU - Frajo-Apor, B.

AU - Kemmler, G.

AU - Mimura, Masaru

AU - Pardeller, S.

AU - Sondermann, C.

AU - Suzuki, T.

AU - Welte, A.

AU - Uchida, Hiroyuki

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Background Health-related quality of life (HRQOL) is significantly affected in individuals with schizophrenia or bipolar I disorder (BD-I). The current study investigated whether symptomatic remission and resilience might differently impact HRQOL in these patients. Methods Fifty-two patients with schizophrenia and 60 patients suffering from BD-I from outpatient mental health services as well as 77 healthy control subjects from the general community were included into a cross-sectional study. HRQOL and resilience were assessed using the WHOQOL-BREF and the Resilience Scale. In patients, psychopathology was quantified by the Positive and Negative Syndrome Scale or the Montgomery Asberg Depression Rating Scale and the Young Mania Rating Scale, respectively. Results Notably, both patient groups showed lower HRQOL and resilience compared to control subjects, non-remitted patients indicated lower HRQOL than remitted ones. The effect of remission on HRQOL was significantly larger in patients with BD-I than in those with schizophrenia but did not explain the difference in HRQOL between groups. Resilience predicted HRQOL in all three groups. When accounting for the effect of resilience among remitted patients, only the difference in HRQOL between schizophrenia patients and control subjects was significant. Conclusion These findings demonstrate the impact of symptomatic remission and resilience on HRQOL of both patients suffering from schizophrenia and BD-I and indicate that these factors are especially relevant for HRQOL of patients with BD-I.

AB - Background Health-related quality of life (HRQOL) is significantly affected in individuals with schizophrenia or bipolar I disorder (BD-I). The current study investigated whether symptomatic remission and resilience might differently impact HRQOL in these patients. Methods Fifty-two patients with schizophrenia and 60 patients suffering from BD-I from outpatient mental health services as well as 77 healthy control subjects from the general community were included into a cross-sectional study. HRQOL and resilience were assessed using the WHOQOL-BREF and the Resilience Scale. In patients, psychopathology was quantified by the Positive and Negative Syndrome Scale or the Montgomery Asberg Depression Rating Scale and the Young Mania Rating Scale, respectively. Results Notably, both patient groups showed lower HRQOL and resilience compared to control subjects, non-remitted patients indicated lower HRQOL than remitted ones. The effect of remission on HRQOL was significantly larger in patients with BD-I than in those with schizophrenia but did not explain the difference in HRQOL between groups. Resilience predicted HRQOL in all three groups. When accounting for the effect of resilience among remitted patients, only the difference in HRQOL between schizophrenia patients and control subjects was significant. Conclusion These findings demonstrate the impact of symptomatic remission and resilience on HRQOL of both patients suffering from schizophrenia and BD-I and indicate that these factors are especially relevant for HRQOL of patients with BD-I.

KW - Bipolar disorder

KW - Quality of life

KW - Remission

KW - Resilience

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=85030714291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030714291&partnerID=8YFLogxK

U2 - 10.1016/j.eurpsy.2017.08.005

DO - 10.1016/j.eurpsy.2017.08.005

M3 - Article

VL - 46

SP - 42

EP - 47

JO - European Psychiatry

JF - European Psychiatry

SN - 0924-9338

ER -